The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

Journal: Nature Communications

Published: 2019-11-20

DOI: 10.1038/s41467-019-13084-7

Affiliations: 25

Authors: 21

Go to article
Institutions Share
Cancer Institute, Erasmus MC, Netherlands 0.14
Center for Personalized Cancer Treatment (CPCT), Netherlands 0.10
Informatics and Bio-computing Program, OICR, Canada 0.10
Department of Medical Oncology, Erasmus MC, Netherlands 0.10
Department of Medical Oncology, RU, Netherlands 0.10
Division of Medical Oncology, NKI, Netherlands 0.08
Oncode Institute, Netherlands 0.07
Division of Oncogenomics, NKI, Netherlands 0.06
Department of Urology, RU, Netherlands 0.05
Sint Franciscus Gasthuis Rotterdam (SFG), Netherlands 0.05
Department of Urology, Erasmus MC, Netherlands 0.02
Cancer Computational Biology Center (CCBC), Erasmus MC, Netherlands 0.02
Division of Molecular Carcinogenesis, NKI, Netherlands 0.02
UMC Utrecht Center for Molecular Medicine (CMM), Netherlands 0.02
Hartwig Medical Foundation, Netherlands 0.02
Department of Biomedical Engineering, TU/e, Netherlands 0.01
Institute for Complex Molecular Systems (ICMS), TU/e, Netherlands 0.01
Department of Medical Biophysics, U of T, Canada 0.01
Department of Pharmacology and Toxicology, U of T, Canada 0.01
UCLA Department of Human Genetics, United States of America (USA) 0.01
UCLA Department of Urology, United States of America (USA) 0.01
UCLA Jonsson Comprehensive Cancer Center (JCCC), United States of America (USA) 0.01